Search Results
May 21, 2026, 08:25 ET Alvin Su, MD, PhD, awarded 2026 OREF Career Development Grant
Foundation (OREF) awarded the 2026 Career Development Grant, its most prestigious award, to Alvin Su, MD, PhD, of Nemours Children's Hospital, Delaware, and Justin Parreno, PhD, and Xinqiao Jia, PhD, of the University of Delaware. Dr Su, who is an attending orthopaedic surgeon specializing in sports medicine
More news about: Orthopaedic Research and Education Foundation
May 21, 2026, 08:23 ET Scientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors
function2."Howard's appointment significantly strengthens our Corporate Board at a pivotal moment for the Company," said Boris Reznik, PhD, Chairman & CEO of Immorta Bio. "As we progress toward clinical development while clearing regulatory approvals and future financing milestones,
More news about: Immorta Bio Inc.
May 21, 2026, 05:30 ET Genethon and Ampersand Biomedicines announce partnership to design novel AAV vectors with enhanced tissue specificity for more effective and better tolerated gene therapies
technology with Genethon's expertise in gene therapy, and opens up new perspectives for novel generation AAV-gene therapies," emphasizes Frédéric Revah PhD., Chief Executive Officer of Genethon."At Ampersand, we aim to address one of medicine's central challenges: delivering therapies exactly where
More news about: Ampersand Biomedicines
May 21, 2026, 01:13 ET Selvita reports Q1 2026 results and launches strategic options review
Selvita Group has been operating since 2007 and employs approximately 900 highly qualified specialists. More than 30% of Selvita's scientists hold a PhD degree. The Group's headquarters and main laboratories are located in Kraków, Poland, with additional research facilities in Poznań, Wrocław, and Zagreb,
More news about: Selvita S.A.
May 20, 2026, 22:23 ET Gain Insight Into Sarcopenia: Nutrition and Lifestyle Strategies to Support Healthy Aging
practitioner awareness of sarcopenia is critical to advancing healthy aging and preserving physical function in older adults," said Stuart Phillip, PhD McMaster University, "Early recognition and intervention can meaningfully influence long-term clinical and functional outcomes."Evidence-Based
More news about: International Life Sciences Institute
May 20, 2026, 16:00 ET NKF Names Dr. Marc Hurlbert Chief Executive Officer
scientist by training, an amazing fundraiser, with strong business acumen, and is a compassionate and caring individual."Dr. Hurlbert earned his PhD in pharmacology from the University of Colorado Health Sciences Center, completed a fellowship at New York University Medical Center, and holds a bachelor's
More news about: National Kidney Foundation
May 20, 2026, 15:20 ET Continuity Biosciences gibt erste klinische Studie am Menschen zur Plattform für präzise Arzneimittelabgabe bei Bauchspeicheldrüsenkrebs bekannt
Bauchspeicheldrüsenkrebs besteht darin, genügend Wirkstoff in den Tumor zu bringen, ohne den Rest des Körpers zu schädigen", sagte Dr. Benjamin Ferguson, M.D., PhD, klinischer Assistenzprofessor für Chirurgie und chirurgischer Onkologe am University of Michigan Medical Center. „Diese Studie wird zeigen, ob eine
More news about: Continuity Biosciences LLC
May 20, 2026, 14:36 ET CureDuchenne Appoints Lidia Gardner, PhD, EMBA, as Vice President of Clinical and Medical Affairs to Advance Patient-Centered Care, Research, and Strategic Partnerships
CureDuchenne, a global nonprofit committed to finding and funding a cure for Duchenne muscular dystrophy, proudly announces the appointment of Lidia Gardner, PhD, EMBA, as its new Vice President of Clinical and Medical Affairs. Dr. Gardner brings more than 15 years of experience spanning clinical strategy, patient
More news about: CureDuchenne
May 20, 2026, 13:30 ET SITC Announces Keynote Speakers Dr. Ton Schumacher and Dr. Catherine J. Wu at its 41st Annual Meeting
May 20, 2026 /PRNewswire/ -- The Society for Immunotherapy of Cancer (SITC) is proud to announce Ton Schumacher, PhD from the Netherlands Cancer Institute as the Keynote Speaker at its
More news about: Society for Immunotherapy of Cancer (SITC)
May 20, 2026, 12:48 ET /C O R R E C T I O N -- Pegasus/PRN Pharmacal/
canine pain management by providing veterinarians a first-of-its-kind option to effectively manage neuropathic pain," said Dr. Heather Davis, DVM, PhD, DACVS-LA, Senior Director of Medical Affairs and Veterinary Services at Pegasus. "The conditional approval of Liavium-CA1 reflects Pegasus' ongoing
More news about: Pegasus/PRN Pharmacal
May 20, 2026, 12:00 ET Hill's Pet Nutrition、2026年Hill'sグローバル・シンポジウムを発表：「健康な皮膚は体内から」をテーマに腸-皮膚軸を探る
。具体的には、腸-皮膚軸、革新的な皮膚科診療のアプローチ方法、猫や小型犬に対するケアなどの内容を掘り下げます。著名な演者には、以下の方々が含まれます。 基調講演の演者、Dr. Domenico Santoro（ DVM, MS, DrSc, PhD, DipACVD, DipECVD, DipACVM）はフロリダ大学獣医学部の皮膚科教授であり、シンポジウムの冒頭で、腸内細菌叢と皮膚との間の関連性についてのご講演を行います。 基調講演の演者、Dr. Elise Robertson（BS
More news about: Hill's Pet Nutrition
May 20, 2026, 11:44 ET Continuity Biosciences anuncia o primeiro ensaio clínico em humanos de uma plataforma de administração precisa de medicamentos para o câncer de pâncreas
centrais no tratamento do câncer de pâncreas é colocar medicamentos suficientes no tumor sem prejudicar o resto do corpo", disse o Dr. Benjamin Ferguson, PhD, professor assistente clínico de cirurgia e oncologista cirúrgico no Centro Médico da Universidade de Michigan. "Este estudo nos dirá se a administração
More news about: Continuity Biosciences LLC
May 20, 2026, 11:43 ET Continuity Biosciences anuncia el primer ensayo clínico en humanos de una plataforma de administración de medicamentos de precisión para el cáncer de páncreas
cáncer de páncreas consiste en lograr que penetre suficiente medicamento en el tumor sin dañar el resto del cuerpo", señaló el Dr. Benjamin Ferguson, MD, PhD, profesor asistente clínico de cirugía y oncólogo quirúrgico en el Centro Médico de la Universidad de Míchigan. "Este estudio nos dirá si la administración
More news about: Continuity Biosciences LLC
May 20, 2026, 10:15 ET Continuity Biosciences annonce le premier essai clinique humain d'une plateforme d'administration de médicaments de précision pour le cancer du pancréas
pancréas est d'administrer suffisamment de médicaments dans la tumeur sans nuire au reste de l'organisme », a déclaré le Dr Benjamin Ferguson, M.D., PhD, professeur adjoint de chirurgie clinique et chirurgien oncologue au Centre médical de l'Université du Michigan. « Cette étude va nous indiquer si l'administration
More news about: Continuity Biosciences LLC
May 20, 2026, 09:21 ET Remepy Reports Strong Clinical Phase IIa Results for Hybridopa™, a First-in-Class Hybrid Drug for Parkinson's Disease
recent meaningful results demonstrate something clinicians have long understood but have struggled to deliver consistently at scale," said Michal Tsur, PhD, Co-CEO of Remepy. "Decades of research show that Parkinson's care works best when dopaminergic therapy is combined with multidisciplinary interventions,
More news about: Remepy
May 20, 2026, 09:00 ET Only 13% of Enterprise Employees Possess The Critical Skills To Understand and Work With AI Agents, Workera Report Finds
scientists at every stage. Workera assessments are designed, deployed, and evaluated by a team of AI scientists led by Taylor Sullivan, PhD, and Marian Pitel-Wali, PhD. Across 14 capabilities, the data reveals a consistent pattern: workforces are strongest where familiar skills apply
More news about: Workera
May 20, 2026, 09:00 ET RESEARCH ALLIANCE CORPORATION III ANNOUNCES PRICING OF $75 MILLION INITIAL PUBLIC OFFERING
subject to customary closing conditions. The Company, sponsored by an affiliate of RA Capital Management, L.P., is led by CEO Matthew Hammond, PhD, MBA and CBO/COO Henry Stusnick. The Company is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition,
More news about: Research Alliance Corporation III
May 20, 2026, 08:56 ET Pictor and Disease Research Limited Formalise Collaboration to Advance Johne's Disease Monitoring Across New Zealand
support more practical and scalable herd health monitoring approaches for farmers and veterinarians across New Zealand." — Jamie Platt, PhD, CEO and Co-founder, Pictor "DRL and Pictor share common values in approaching assay development from a multi-analyte perspective. This
More news about: Pictor Holdings Inc.
May 20, 2026, 08:56 ET Pictor and Disease Research Limited Formalise Collaboration to Advance Johne's Disease Monitoring Across New Zealand
support more practical and scalable herd health monitoring approaches for farmers and veterinarians across New Zealand." — Jamie Platt, PhD, CEO and Co-founder, Pictor "DRL and Pictor share common values in approaching assay development from a multi-analyte perspective. This
More news about: Pictor Holdings Inc.
May 20, 2026, 08:30 ET IVDR Process Overview with Case-study on IVDR Implementation for Custom LDT Assays, Upcoming Webinar Hosted by Xtalks
Cerba Research, Lorella Di Donato, Chief Laboratory & Operations Officer; Martin Roberge, PhD, Director, Development & Innovation; and Marie-Laure Delalande, Head of IVD Operations, for the live webinar on Tuesday, June 9, 2026, at 11am EDT
More news about: Xtalks
May 20, 2026, 08:00 ET Whitehawk Therapeutics to Participate in the TD Cowen 7th Annual Oncology Innovation Summit
technologies to established tumor biology to efficiently deliver improved antibody drug conjugate (ADC) cancer treatments, today announced Dave Lennon, PhD, President and CEO, will participate in a virtual fireside chat as part of the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO &
More news about: Whitehawk Therapeutics, Inc.
May 20, 2026, 08:00 ET Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
challenges in treating pancreatic cancer is getting enough drug into the tumor without harming the rest of the body," said Dr. Benjamin Ferguson, M.D., PhD, Clinical Assistant Professor of Surgery and surgical oncologist at the University of Michigan Medical Center. "This study will tell us whether targeted,
More news about: Continuity Biosciences LLC
May 20, 2026, 08:00 ET Continuity Biosciences Announces First-in-Human Clinical Trial of Precision Drug Delivery Platform for Pancreatic Cancer
challenges in treating pancreatic cancer is getting enough drug into the tumor without harming the rest of the body," said Dr. Benjamin Ferguson, M.D., PhD, Clinical Assistant Professor of Surgery and surgical oncologist at the University of Michigan Medical Center. "This study will tell us whether targeted,
More news about: Continuity Biosciences LLC
May 20, 2026, 08:00 ET Vermont Governor Signs Rare Disease Advisory Council into Law
Vermont, where our legislators listen to their constituents and chose to learn more about Vermonters living with rare diseases," said Leslie Kanat, PhD, a NORD volunteer and parent of a child with Fragile X Syndrome, who testified before the Vermont legislature in support of the bill. "Approximately
More news about: National Organization for Rare Disorders (NORD®)
May 20, 2026, 05:30 ET Theme and First Keynote Speakers Announced for 20th-Anniversary Global Wellness Summit in Phuket, Thailand
keynoting: William Heinecke, founder and chairman of Minor International, a global powerhouse in hospitality, food and lifestyle, and Andrea Maier, MD PhD FRACP, one of the world's leading experts on longevity medicine and Oon Chiew Seng Professor in Medicine, co-founder of NUS Academy of Healthy Longevity
More news about: Global Wellness Summit